DOE Completes Working Drafts of Human Chromosomes 5, 16, and 19
April 2000
Researchers in the U.S. Department of Energy (DOE) Human Genome Program have
achieved "working drafts" of the complete DNA sequences for human chromosomes
5, 16, and 19, thus fulfilling DOE's share of a major goal in the international
U.S. Human Genome Project (HGP). All data have been deposited in the human DNA
sequence database, GenBank, and are freely available through the Internet. Working
drafts for the remaining human chromosomes are expected later this spring from
other participants in the international HGP.
These three chromosome drafts were constructed by the DOE Joint Genome Institute
(JGI), with data analysis by the Computational Bioinformatics group at Oak Ridge
National Laboratory. The JGI is part of a consortium of five major international
partners working together to provide by 2003 a high-quality reference sequence
for the entire human genome—the ultimate goal of the Human Genome Project.
These newly completed working drafts provide a road map to an estimated 90%
of genes on the three chromosomes, offering scientists worldwide an invaluable
resource for improving human health and combating disease. Knowledge about genes
will increase understanding of how genetics influences the development of disease,
help researchers find genes associated with particular diseases, and aid in
the development of new pharmaceuticals.
DNA Sequencing
DNA sequencing determines the exact order of the individual chemical building
blocks, or bases, that make up the human genome.
DOWNLOADABLE GRAPHIC "DNA:
THE MOLECULE OF LIFE"
Even though a draft does contain some gaps and errors, it provides a scaffold
for the ultimate entire reference genome sequence and gives researchers advance
access to much of the "gold" of the genome—its genes. Scientists believe that
a high-quality sequence is critical for recognizing control components of genes
that are very important in understanding human biology and such disorders as
heart disease, cancer, and diabetes. These complex diseases are thought to be
influenced by multiple genes interacting among themselves and with environmental
factors.
DOWNLOADABLE GRAPHIC: "FROM
DNA TO HUMANS"
Caption: The flow from DNA to protein to cells (interacting with environmental
factors) to people (phenotypes).
Genes on Chromosomes 5, 16, and 19
Sequencing and analysis of chromosomes 5, 16, and 19 have enabled researchers
to characterize in detail a number of genes associated with diseases. Some specific
examples follow.
Chromosome 5. Human chromosomes range in size from about 50 million to 260
million bases. Chromosome 5, with an estimated 194 million bases, represents
about 6% of the human genome. Last year, researchers at Lawrence Berkeley National
Laboratory discovered two genes on chromosome 5 that contribute to the development
of asthma, a complex disease believed to be linked to a number of genes. Asthma
affects more than 5% of people in the United States; the number has doubled
over the last 15 years and continues to rise. Further work may reveal additional
genes or biological pathways linked to asthma and may suggest potential target
for drug interventions. Other disease-linked genes on chromosome 5 include those
for a type of dwarfism, severe combined immunodeficiency, schizophrenia, colorectal
cancer, basal cell carcinoma, deafness, acute myelogenous leukemia, susceptibility
to obesity, and atrial septal defect (a heart defect).
DOWNLOADABLE GRAPHIC "HEALTH
OR DISEASE? "
Caption: Some DNA variations have no negative effects; others may lead to
disease or increased susceptibilities to disease, as well as different reactions
to drugs.
DOWNLOADABLE GRAPHIC "GENE
CHIPS REVEAL SUSCEPTIBILITIES"
Caption: Gene expression chip.
Chromosome 16.Chromosome 16 contains about 98 million bases, or some
3% of the human genome. Studies have implicated a gene on chromosome 16 in the
development of adult polycystic kidney disease (PKD), the most common potentially
fatal disease caused by a defect in a single gene. An estimated 5 million people
worldwide have PKD (500,000 in the United States), and half require dialysis
or a kidney transplant by the age of 60. Knowledge gained through HGP data will
pave the way for earlier diagnostic methods and more effective treatments of
this disease.
Other major ailments associated with chromosome 16 are inflammatory bowel
disease (ulcerative colitis and Crohn disease); breast and prostate cancers;
Batten's Disease (a juvenile-onset neurodegenerative disorder); Fanconi anemia
(a rare disease characterized by skeletal abnormalities, bone marrow failure,
and a predisposition to cancer); and acute nonlymphocytic leukemia.
Chromosome 19. At 60 million bases in length, human chromosome 19 contains
about 2% of the human genome, and data suggest that it is particularly gene
rich. Important genes that have been the focus of intense study include three
involved in the repair of DNA damage caused by exposure to radiation and other
environmental pollutants. Studies of DNA-repair genes also may yield insights
into the development of cancers, many of which are caused by defects in DNA-repair
pathways.
Another important gene family studied on chromosome 19 comprises some 60 genes
involved in detoxifying and excreting chemicals foreign to the body. This gene
family may influence individual responses to such substances as pollutants and
medicines. Other identified chromosome 19 genes are associated with a rare type
of migraine, myotonic dystrophy, atherosclerosis, and diabetes mellitus.
DNA Sequencing: A Prelude to Understanding Function
Interpreting the functions of individual genes and other DNA sequences such
as those that regulate gene activity is a task that will extend well into this
new century. The multidisciplinary teams and resources located at DOE national
laboratories are uniquely poised to play prominent roles in these future explorations.
The HGP already has revolutionized biology by providing tools and resources
for basic research and has catalyzed the growth of the life sciences and bioengineering
industries. Today, researchers worldwide use HGP data and associated analytical
technologies to devise creative applications in an expanding array of fields.
These fields include agriculture, forensics (identification technologies), environmental
cleanup, industrial processes, and generation of new energy resources.
Background on the HGP
The DOE Human Genome Program began as a 1986 initiative by the DOE Biological
and Environmental Research Program. The goal was to use newly developed DNA-analysis
technologies in fulfilling a longstanding mandate from Congress to assess the
health effects of radiation. In 1990, at the request of Congress, DOE and NIH
formally began the joint U.S. Human Genome Project, which was expected to cost
$3 billion and last 15 years. The collaborative effort aimed to find the estimated
80,000 human genes and determine the sequence of the 3 billion DNA bases that
underlie all of human biology and account for its diversity, including disease.
The early phase of the U.S. project was characterized by efforts to create the
biological, instrumentation, and computing resources necessary for efficient
production-scale DNA sequencing. In 1993 remarkable technological progress led
to a revised 5-year plan that projected goals through FY 1998. The current plan,
published in the October 23, 1998, issue of Science, projects a finishing date
of 2003.
For More Information
•Ari Patrinos: 301/903-3251, ari.patrinos@science.doe.gov
•Marvin Frazier: 301/903-5468, marvin.frazier@science.doe.gov
•Human Genome Project Information: www.ornl.gov/hgmis
•Human Genome Project Information Online Media Kit: www.ornl.gov/hgmis/resource/media.shtml
•Joint Genome Institute: www.jgi.doe.gov
•Computational Biosciences: genome.ornl.gov/jgi
|